What amount sold does HUBOT, INC. report in Form D filings?

The latest linked filings report $5.5M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was HUBOT, INC.'s most recent SEC filing?

HUBOT, INC.'s most recent Form D filing was on 2026-04-07.

How many investors does HUBOT, INC. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does HUBOT, INC. offer?

HUBOT, INC.'s SEC Form D filings indicate equity offerings.

HUBOT, INC.

CIK: 0002127640·Pharmaceuticals·SOUTH BEND, IN·Corporation

Reported Sold

$5,500,001

Total Filings

Identified Offerings

Last Filed

Apr 7, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Apr 7, 2026Form D — New notice

Reported sold: $5,500,001 · Target: $5,500,001

Rule 506(b)·1 investor·Section 4(1), Section 4(3)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$25,000,001 - $100,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$5,500,001

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 7, 2026	New	$5,500,001	$5,500,001	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Crosslink Therapeutics Inc.

Pharmaceuticals

Offering target: $5,500,000

Filed Oct 20, 2026